Amgen (HKSE:04332) Days Sales Outstanding

: 74.75 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

Amgen's average Accounts Receivable for the three months ended in Dec. 2023 was HK$52,434 Mil. Amgen's Revenue for the three months ended in Dec. 2023 was HK$64,009 Mil. Hence, Amgen's Days Sales Outstanding for the three months ended in Dec. 2023 was 74.75.

The historical rank and industry rank for Amgen's Days Sales Outstanding or its related term are showing as below:

HKSE:04332' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.68 Med: 56.03 Max: 83.07
Current: 79.09

During the past 13 years, Amgen's highest Days Sales Outstanding was 83.07. The lowest was 46.68. And the median was 56.03.

HKSE:04332's Days Sales Outstanding is ranked worse than
57.9% of 1000 companies
in the Drug Manufacturers industry
Industry Median: 71.685 vs HKSE:04332: 79.09

Amgen's Days Sales Outstanding increased from Dec. 2022 (72.94) to Dec. 2023 (74.75).

Amgen Days Sales Outstanding Historical Data

The historical data trend for Amgen's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amgen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

59.71

61.80

65.98

72.57

82.95

Amgen Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															72.94	84.11	75.61	79.17	74.75

Competitive Comparison

For the Drug Manufacturers - General subindustry, Amgen's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amgen Days Sales Outstanding Distribution

For the Drug Manufacturers industry and Healthcare sector, Amgen's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Amgen's Days Sales Outstanding falls into.

Amgen Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Amgen's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (43310.18	+	56761.626)	/	2 )	/	220158.262	*	365
=	50035.903					/	220158.262	*	365
=	82.95

Amgen's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (48106.132	+	56761.626)	/	2 )	/	64009.121	*	365 / 4
=	52433.879					/	64009.121	*	365 / 4
=	74.75

Amgen (HKSE:04332) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Amgen Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Amgen's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Amgen (HKSE:04332) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amgen Inc (HKSE:04332) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

AMGN:USA AMG N:Mexico AMGd:UK 0R0T:UK AMG:Germany AMGN34:Brazil AMGN:Austria AMGN:Argentina

Address

One Amgen Center Drive, Thousand Oaks, CA, USA, 91320-1799

Website

https://www.amgen.com

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Amgen (HKSE:04332) Headlines

No Headlines